New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|August 1, 1999
Supplements and Featured Publications
- Vascular Compliance: Clinical and Managed Care Issues
- Volume 5
- Issue 12 Suppl
Can Arterial Stiffness be Reversed? And If So, What are the Benefits?
Author(s)Michel E. Safar, MD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Introductionabout 27 years ago
Perindopril: Clinical Profile of a Unique ACE Inhibitorabout 27 years ago
Issues in Vascular Complianceabout 27 years ago
Selected Abstractsabout 27 years ago
BibliographyAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Treatment for Sanfilippo Syndrome Type A
2
Real-World Data: FACT vs Non-FACT CAR T Outcomes Compared
3
No Blood Biomarker Is Ready to Pick Psoriasis Therapy
4
Oral GLP-1s, Medicare Bridge Reshape Obesity Care: Holly Lofton, MD
5